FDA Reports Deaths Linked to Breast Implants, Speak with Dr. Williams Gradishar to Learn About Anaplastic Large Cell Lymphoma (BIA-ALCL)

In 2011, the FDA identified a possible association between breast implants and the development of anaplastic large cell lymphoma (ALCL), a rare type of non-Hodgkin's lymphoma.

William Gradishar, MD, Director of the Maggie Daley Center for Women's Cancer at Northwestern Memorial Hospital is available to share his thoughts on Anaplastic Large Cell Lymphoma (BIA-ALCL) and the study.